CA19-9 trajectories are predictive of underlying pancreatic cancer in patients with new-onset diabetes and may be useful for routine testing in this high-risk population. Our Dr. Johannes Fahrmann presented these results at #AACR26. Learn more:
http://
bit.ly/4sNLwUv #EndCancer